Cargando…
Osteogenic growth peptide is a potent anti-inflammatory and bone preserving hormone via cannabinoid receptor type 2
The endocannabinoid system consists mainly of 2-arachidonoylglycerol and anandamide, as well as cannabinoid receptor type 1 and type 2 (CB2). Based on previous studies, we hypothesized that a circulating peptide previously identified as osteogenic growth peptide (OGP) maintains a bone-protective CB2...
Autores principales: | Raphael-Mizrahi, Bitya, Attar-Namdar, Malka, Chourasia, Mukesh, Cascio, Maria G, Shurki, Avital, Tam, Joseph, Neuman, Moshe, Rimmerman, Neta, Vogel, Zvi, Shteyer, Arie, Pertwee, Roger G, Zimmer, Andreas, Kogan, Natalya M, Bab, Itai, Gabet, Yankel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9154745/ https://www.ncbi.nlm.nih.gov/pubmed/35604006 http://dx.doi.org/10.7554/eLife.65834 |
Ejemplares similares
-
The Anti-Tumorigenic Role of Cannabinoid Receptor 2 in Non-Melanoma Skin Cancer
por: Iden, Jennifer Ana, et al.
Publicado: (2023) -
CB2 Cannabinoid Receptor Targets Mitogenic Gi Protein–Cyclin D1 Axis in Osteoblasts
por: Ofek, Orr, et al.
Publicado: (2011) -
The Anti-Tumorigenic Role of Cannabinoid Receptor 2 in Colon Cancer: A Study in Mice and Humans
por: Iden, Jennifer Ana, et al.
Publicado: (2023) -
HU-671, a Novel Oleoyl Serine Derivative, Exhibits Enhanced Efficacy in Reversing Ovariectomy-Induced Osteoporosis and Bone Marrow Adiposity
por: Baraghithy, Saja, et al.
Publicado: (2019) -
Erythropoietin treatment in murine multiple myeloma: immune gain and bone loss
por: Deshet-Unger, Naamit, et al.
Publicado: (2016)